Loading
A phase 2 trial of cAPOX (capecitabine, oxaliplatin) and bevacizumab (glioblastoma use) in colorectal cancer, run by The First Affiliated Hospital with Nanjing Medical University, not yet recruiting.
SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer. is a phase 2, interventional study registered as NCT06835179 by The First Affiliated Hospital with Nanjing Medical University, with a registry enrolment figure of 28 participants, started 2025-02 and due to reach its primary completion in 2027-02. Interventions recorded: SBRT; PD-1 Inhibitors; CapeOX + bevacizumab. Conditions listed: Unresectable Metastatic Colorectal Cancer; Microsatellite Stable (MSS) Colorectal Cancer (CRC); RAS-mutant Colorectal Cancer. Primary outcome: Objective response rate (ORR rate). Colorectal eligibility wording from the registry: "* Histologically confirmed colorectal adenocarcinoma". No results are recorded here; the registry entry is the source.
Shares Bevacizumab (glioblastoma use), CAPOX (capecitabine, oxaliplatin), SBRT / SABR (stereotactic radiotherapy), Platinum agents and the tag colorectal-deep-dive.
Shares Bevacizumab (glioblastoma use), CAPOX (capecitabine, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Bevacizumab (glioblastoma use), CAPOX (capecitabine, oxaliplatin), Platinum agents, Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Bevacizumab (glioblastoma use), SBRT / SABR (stereotactic radiotherapy), Platinum agents, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares Bevacizumab (glioblastoma use), Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Platinum agents, Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares CAPOX (capecitabine, oxaliplatin), Platinum agents, Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.